Esketamine hydrochloride - Generic Drug Details
✉ Email this page to a colleague
What are the generic drug sources for esketamine hydrochloride and what is the scope of patent protection?
Esketamine hydrochloride
is the generic ingredient in one branded drug marketed by Janssen Pharms and is included in one NDA. There are seven patents protecting this compound. Additional information is available in the individual branded drug profile pages.Esketamine hydrochloride has sixty patent family members in twenty-four countries.
One supplier is listed for this compound.
Summary for esketamine hydrochloride
| International Patents: | 60 |
| US Patents: | 7 |
| Tradenames: | 1 |
| Applicants: | 1 |
| NDAs: | 1 |
| Finished Product Suppliers / Packagers: | 1 |
| Raw Ingredient (Bulk) Api Vendors: | 23 |
| Clinical Trials: | 134 |
| Patent Applications: | 33 |
| What excipients (inactive ingredients) are in esketamine hydrochloride? | esketamine hydrochloride excipients list |
| DailyMed Link: | esketamine hydrochloride at DailyMed |
Recent Clinical Trials for esketamine hydrochloride
Identify potential brand extensions & 505(b)(2) entrants
| Sponsor | Phase |
|---|---|
| Reinier de Graaf Groep | Phase 3 |
| Academisch Medisch Centrum - Universiteit van Amsterdam (AMC-UvA) | Phase 3 |
| Stichting ZiektekostenVerzekering Krijgsmacht | Phase 3 |
Anatomical Therapeutic Chemical (ATC) Classes for esketamine hydrochloride
Paragraph IV (Patent) Challenges for ESKETAMINE HYDROCHLORIDE
| Tradename | Dosage | Ingredient | Strength | NDA | ANDAs Submitted | Submissiondate |
|---|---|---|---|---|---|---|
| SPRAVATO | Nasal Spray | esketamine hydrochloride | 28 mg | 211243 | 3 | 2023-03-06 |
US Patents and Regulatory Information for esketamine hydrochloride
| Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Exclusivity Expiration |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Janssen Pharms | SPRAVATO | esketamine hydrochloride | SPRAY;NASAL | 211243-001 | Mar 5, 2019 | RX | Yes | Yes | ⤷ Subscribe | ⤷ Subscribe | ⤷ Subscribe | ||||
| Janssen Pharms | SPRAVATO | esketamine hydrochloride | SPRAY;NASAL | 211243-001 | Mar 5, 2019 | RX | Yes | Yes | ⤷ Subscribe | ⤷ Subscribe | ⤷ Subscribe | ||||
| Janssen Pharms | SPRAVATO | esketamine hydrochloride | SPRAY;NASAL | 211243-001 | Mar 5, 2019 | RX | Yes | Yes | ⤷ Subscribe | ⤷ Subscribe | ⤷ Subscribe | ||||
| Janssen Pharms | SPRAVATO | esketamine hydrochloride | SPRAY;NASAL | 211243-001 | Mar 5, 2019 | RX | Yes | Yes | ⤷ Subscribe | ⤷ Subscribe | ⤷ Subscribe | ||||
| Janssen Pharms | SPRAVATO | esketamine hydrochloride | SPRAY;NASAL | 211243-001 | Mar 5, 2019 | RX | Yes | Yes | ⤷ Subscribe | ⤷ Subscribe | ⤷ Subscribe | ||||
| Janssen Pharms | SPRAVATO | esketamine hydrochloride | SPRAY;NASAL | 211243-001 | Mar 5, 2019 | RX | Yes | Yes | ⤷ Subscribe | ⤷ Subscribe | ⤷ Subscribe | ||||
| >Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >TE | >Type | >RLD | >RS | >Patent No. | >Patent Expiration | >Product | >Substance | >Delist Req. | >Exclusivity Expiration |
International Patents for esketamine hydrochloride
| Country | Patent Number | Title | Estimated Expiration |
|---|---|---|---|
| Japan | 2021054829 | Ｖａｌ６６Ｍｅｔ（ＳＮＰ ｒｓ６２６５）遺伝子型特異的投薬レジメン及びうつ病の治療のための方法 (Val66Met (SNP rs6265) GENOTYPE SPECIFIC DOSING REGIMENS AND METHODS FOR TREATMENT OF DEPRESSION) | ⤷ Subscribe |
| South Korea | 20170054470 | VAL66MET (SNP rs6265) 유전자형 특이적 투여 계획 및 우울증 치료 방법 (VAL66MET SNP rs6265 VAL66MET SNP rs6265 GENOTYPE SPECIFIC DOSING REGIMENS AND METHODS FOR THE TREATMENT OF DEPRESSION) | ⤷ Subscribe |
| Japan | 2017528483 | Ｖａｌ６６Ｍｅｔ（ＳＮＰ ｒｓ６２６５）遺伝子型特異的投薬レジメン及びうつ病の治療のための方法 | ⤷ Subscribe |
| South Korea | 102217616 | ⤷ Subscribe | |
| Israel | 279119 | משטרי מינון ספציפים לגנוטייפ val66met (snp rs6265) ושיטות לטיפול בדיכאון (Val66met (snp rs6265) genotype specific dosing regimens and methods for the treatment of depression) | ⤷ Subscribe |
| Australia | 2019200424 | Pharmaceutical composition of S-ketamine hydrochloride | ⤷ Subscribe |
| >Country | >Patent Number | >Title | >Estimated Expiration |
